1. Home
  2. IMNM vs GPK Comparison

IMNM vs GPK Comparison

Compare IMNM & GPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunome Inc.

IMNM

Immunome Inc.

N/A

Current Price

$18.76

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Logo Graphic Packaging Holding Company

GPK

Graphic Packaging Holding Company

N/A

Current Price

$10.90

Market Cap

2.5B

ML Signal

N/A

Company Overview

Basic Information
Metric
IMNM
GPK
Founded
2006
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Containers/Packaging
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.5B
IPO Year
2020
2007

Fundamental Metrics

Financial Performance
Metric
IMNM
GPK
Price
$18.76
$10.90
Analyst Decision
Strong Buy
Hold
Analyst Count
17
11
Target Price
★ $35.13
$12.10
AVG Volume (30 Days)
1.4M
★ 8.1M
Earning Date
11-09-2026
11-03-2026
Dividend Yield
N/A
★ 4.08%
EPS Growth
★ 51.40
N/A
EPS
N/A
★ 0.01
Revenue
$6,941,000.00
★ $8,617,000,000.00
Revenue This Year
N/A
$0.33
Revenue Next Year
N/A
$1.91
P/E Ratio
★ N/A
$1,079.50
Revenue Growth
N/A
★ N/A
52 Week Low
$16.41
$8.15
52 Week High
$30.06
$16.61

Technical Indicators

Market Signals
Indicator
IMNM
GPK
Relative Strength Index (RSI) 46.46 61.67
Support Level $17.18 $10.09
Resistance Level $23.30 $11.31
Average True Range (ATR) 1.39 0.46
MACD 0.20 0.13
Stochastic Oscillator 25.98 67.39

Price Performance

Historical Comparison
IMNM
GPK

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

About GPK Graphic Packaging Holding Company

Graphic Packaging Holding Co is a holding company that manufactures and sells a variety of paper-based consumer packaging products through its subsidiaries. The company's reportable segments are; Americas Paperboard Packaging, and International Paperboard Packaging. The majority of the revenue is generated from its Americas Paperboard Packaging segment which includes paperboard packaging sold predominantly to consumer packaged goods (CPG) companies and cups, lids and food containers sold to foodservice companies and quick-service restaurants (QSR) serving the food, beverage, and consumer product markets in the Americas. Geographically, the company operates in Americas, Europe and Asia Pacific regions.

Share on Social Networks: